Oncotelic Therapeutics
(OTC) OTLC
Oncotelic Therapeutics Financials at a Glance
Market Cap
$15.32M
Revenue (TTM)
$0.00
Net Income (TTM)
$1.67M
EPS (TTM)
$-0.00
P/E Ratio
-8.44
Dividend
$0.00
Beta (Volatility)
0.18 (Low)
Dividend
$0.00
Beta (Volatility)
0.18 (Low)
Price
$0.03
Volume
149,219
Open
$0.05
Price
$0.03
Volume
149,219
Open
$0.05
Previous Close
$0.03
Daily Range
$0.03 - $0.05
52-Week Range
$0.01 - $0.11
Dividend
$0.00
Beta (Volatility)
0.18 (Low)
Price
$0.03
Volume
149,219
Open
$0.05
Previous Close
$0.03
Daily Range
$0.03 - $0.05
52-Week Range
$0.01 - $0.11
OTLC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Oncotelic Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
40
CEO
Vuong Trieu, PhD
Website
www.oncotelic.comHeadquarters
Agoura Hills, CA 91301, US
OTLC Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-19%
Return on Capital
-9%
Return on Assets
-6%
Earnings Yield
-11.85%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$15.32M
Shares Outstanding
442.60M
Volume
149.22K
Short Interest
0.00%
Avg. Volume
303.94K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$3.58B
EBITDA
$3.55M
Operating Cash Flow
$740.27K
Capital Expenditure
$3.00
Free Cash Flow
$740.27K
Cash & ST Invst.
$86.13K
Total Debt
$13.09M
Oncotelic Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$15.32M
N/A
Market Cap/Employee
$589.33K
N/A
Employees
26
N/A
Net Income
$1.05M
+68.3%
EBITDA
$828.55K
+73.1%
Quarterly Fundamentals
Net Cash
$17.00M
-33.0%
Accounts Receivable
$3.98K
-79.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$17.41M
+63.6%
Return on Assets
-5.93%
N/A
Return on Invested Capital
-8.54%
N/A
Free Cash Flow
$307.03K
-114.4%
Operating Cash Flow
$307.02K
-114.4%